Indian pharma sector revenue growth to ease to 7-9% in FY26: Crisil (Soban News)

Crisil projects India pharma growth at 7-9% in FY26 as exports to regulated markets slow after a US high base while domestic sales benefit from tax cuts and launches​Crisil projects India pharma growth at 7-9% in FY26 as exports to regulated markets slow after a US high base while domestic sales benefit from tax cuts and launches ​Latest News [ SOBAN NEWS: International and National ]